BUDA, ALESSANDRO ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 7.151
AS - Asia 3.177
EU - Europa 2.874
SA - Sud America 472
Continente sconosciuto - Info sul continente non disponibili 318
AF - Africa 86
OC - Oceania 11
Totale 14.089
Nazione #
US - Stati Uniti d'America 6.750
SG - Singapore 1.095
CN - Cina 729
IT - Italia 697
HK - Hong Kong 421
DE - Germania 407
RU - Federazione Russa 400
VN - Vietnam 400
BR - Brasile 352
SE - Svezia 339
CA - Canada 326
IE - Irlanda 235
GB - Regno Unito 178
UA - Ucraina 156
IN - India 149
FR - Francia 140
FI - Finlandia 70
BD - Bangladesh 69
TR - Turchia 51
MX - Messico 43
DK - Danimarca 41
AR - Argentina 39
ES - Italia 39
IQ - Iraq 39
JP - Giappone 39
AT - Austria 35
PL - Polonia 27
ZA - Sudafrica 27
BE - Belgio 25
NL - Olanda 24
SA - Arabia Saudita 23
PH - Filippine 21
CO - Colombia 19
PK - Pakistan 19
EC - Ecuador 18
KR - Corea 18
CZ - Repubblica Ceca 16
ID - Indonesia 15
MA - Marocco 12
AE - Emirati Arabi Uniti 11
UZ - Uzbekistan 11
VE - Venezuela 11
CH - Svizzera 10
EG - Egitto 10
EU - Europa 10
MY - Malesia 10
PY - Paraguay 10
AU - Australia 9
IR - Iran 9
KE - Kenya 9
PE - Perù 8
PT - Portogallo 8
RO - Romania 7
TN - Tunisia 7
A2 - ???statistics.table.value.countryCode.A2??? 5
AZ - Azerbaigian 5
BG - Bulgaria 5
CL - Cile 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
GT - Guatemala 5
JM - Giamaica 5
LB - Libano 5
RS - Serbia 5
TH - Thailandia 5
UY - Uruguay 5
BO - Bolivia 4
CR - Costa Rica 4
KZ - Kazakistan 4
OM - Oman 4
PS - Palestinian Territory 4
AL - Albania 3
ET - Etiopia 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KG - Kirghizistan 3
PA - Panama 3
SC - Seychelles 3
SN - Senegal 3
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
NI - Nicaragua 2
PR - Porto Rico 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
Totale 13.774
Città #
Ann Arbor 1.191
Ashburn 731
Singapore 649
Fairfield 387
Hong Kong 372
Houston 343
San Jose 338
Chandler 329
Woodbridge 322
Wilmington 268
Toronto 236
Dublin 228
Frankfurt am Main 187
Milan 177
Dearborn 169
New York 165
Seattle 158
Jacksonville 143
Cambridge 138
Ho Chi Minh City 130
Los Angeles 119
Beijing 107
Santa Clara 101
The Dalles 91
Princeton 90
Hanoi 83
Dallas 77
Chicago 75
Shanghai 69
Nanjing 68
Boardman 66
Lissone 60
Altamura 53
Buffalo 53
Munich 50
São Paulo 48
Lauterbourg 45
Lawrence 43
Fremont 42
San Diego 35
Rome 33
Council Bluffs 32
Orem 32
Hefei 31
Vienna 31
Tokyo 30
London 29
Nanchang 29
Helsinki 28
Montreal 26
Brussels 25
Guangzhou 25
Chennai 24
Lachine 24
Moscow 23
Da Nang 22
Atlanta 20
Falls Church 20
Johannesburg 19
Pune 18
Warsaw 17
Baghdad 16
Brooklyn 16
Denver 16
Ottawa 16
Turku 16
Amsterdam 14
Hangzhou 14
Jinan 13
Kunming 13
Monza 13
Nuremberg 13
Poplar 13
Seoul 13
Shenyang 13
Washington 13
Columbus 12
Dhaka 12
Haiphong 12
Hebei 12
Phoenix 12
Rio de Janeiro 12
Andover 11
Biên Hòa 11
Boston 11
Brno 11
Düsseldorf 11
Manchester 11
Paris 11
Bologna 10
Mexico City 10
San Francisco 10
Tashkent 10
Curitiba 9
Jeddah 9
Mumbai 9
Newark 9
Secaucus 9
Tianjin 9
Brasília 8
Totale 9.037
Nome #
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 546
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 484
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 463
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 454
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 401
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 385
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 379
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 371
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 370
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 368
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 368
Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison 366
Sentinel node biopsy in endometrial cancer: an update 355
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 353
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 343
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 337
Effects of Peritoneal Ropivacaine Nebulization for Pain Control After Laparoscopic Gynecologic Surgery 326
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancyc 320
Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: Our experience and literature review 319
The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study 318
Optimizing strategies for sentinel lymph node mapping in early-stage cervical and endometrial cancer: Comparison of real-time fluorescence with indocyanine green and methylene blue 316
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 315
Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer 310
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 303
Near-Infrared Sentinel Lymph Node Mapping With Indocyanine Green Using the VITOM II ICG Exoscope for Open Surgery for Gynecologic Malignancies 299
Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy 296
Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer: Validity of pathological response as surrogate endpoint of survival 294
Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial 283
Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors 270
Primary insular carcinoid of the ovary with carcinoid heart disease: Unfavourable outcome of a case 266
Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm) 266
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 254
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 253
Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection 252
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections 248
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma 248
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 238
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience 229
Endometriosis-related spontaneous hemoperitoneum in pregnancy: A case series 197
Eviscerazione pelvica 197
Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review 196
Prognostic factors in patients with vulvar cancer: the VULCAN study 180
Cervical injection for sentinel lymph nodes detection in endometrial cancers is controversial: response to comments 178
KRas-LCS6 polymorphism does not impact on outcomes in ovarian cancer 167
Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer 151
Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study 146
Qualità di vita dopo trapianto di fegato per epatite fulminante 111
Totale 14.089
Categoria #
all - tutte 44.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.871


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022725 0 110 81 69 58 71 44 52 31 67 60 82
2022/20231.180 102 387 101 127 66 195 11 58 77 10 34 12
2023/2024803 21 22 44 45 100 219 200 27 28 3 3 91
2024/20251.727 94 181 108 82 128 81 100 74 158 305 164 252
2025/20265.063 603 231 376 562 560 269 778 211 425 397 361 290
2026/2027152 114 38 0 0 0 0 0 0 0 0 0 0
Totale 14.089